We are live on ! Find out more
CPXX

CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX

Delisted

CPXX was delisted on the 11th of July, 2016.

Back to rankings

0 hedge funds and large institutions have $0 invested in CELATOR PHARMACEUTICALS INC. COMMON STOCK in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 117 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 119 → 0 (-119)

100% less funds holding in top 10

Funds holding in top 10: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $944M → $0 (-$944M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 117

Holders
–
Holders Change
-119
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
117
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CC
Caxton Corporation
New Jersey
-$67.4M
2
AAM
Alpine Associates Management
Florida
-$66.9M
3
MF
Magnetar Financial
Illinois
-$48M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$37.9M
5
ACA
Avoro Capital Advisors
New York
-$33.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
51
TIAA CREF Investment Management
New York
– -$2.85M -94,332 Closed
CS
52
Credit Suisse
Switzerland
– -$2.66M -88,087 Closed
California Public Employees Retirement System
53
California Public Employees Retirement System
California
– -$2.65M -87,900 Closed
PAM
54
Panagora Asset Management
Massachusetts
– -$2.18M -72,289 Closed
CCM
55
Chicago Capital Management
Illinois
– -$2.11M -70,000 Closed
California State Teachers Retirement System (CalSTRS)
56
California State Teachers Retirement System (CalSTRS)
California
– -$2.07M -68,493 Closed
Charles Schwab
57
Charles Schwab
California
– -$1.86M -61,600 Closed
KAM
58
Kassirer Asset Management
Ontario, Canada
– -$1.81M -60,000 Closed
Ameriprise
59
Ameriprise
Minnesota
– -$1.79M -59,227 Closed
AllianceBernstein
60
AllianceBernstein
Tennessee
– -$1.73M -57,200 Closed
HA
61
Havens Advisors
New York
– -$1.69M -56,128 Closed
KC
62
Kellner Capital
New York
– -$1.66M -55,100 Closed
OTC
63
Opera Trading Capital
France
– -$1.66M -55,000 Closed
Walleye Trading
64
Walleye Trading
New York
– -$1.61M -53,389 Closed
Susquehanna International Group
65
Susquehanna International Group
Pennsylvania
– -$1.58M -52,340 Closed
TA
66
Teachers Advisors
New York
– -$1.58M -52,271 Closed
Swiss National Bank
67
Swiss National Bank
Switzerland
– -$1.51M -50,100 Closed
VOAM
68
Vertex One Asset Management
British Columbia, Canada
– -$1.37M -45,500 Closed
Bank of America
69
Bank of America
North Carolina
– -$1.36M -45,093 Closed
IA
70
IndexIQ Advisors
New York
– -$1.17M -38,780 Closed
State of Wisconsin Investment Board
71
State of Wisconsin Investment Board
Wisconsin
– -$1.14M -37,600 Closed
Creative Planning
72
Creative Planning
Kansas
– -$1.09M -36,068 Closed
AL
73
Airain Ltd
Guernsey
– -$1.08M -35,640 Closed
RhumbLine Advisers
74
RhumbLine Advisers
Massachusetts
– -$1.02M -33,659 Closed
VKH
75
Virtu KCG Holdings
New York
– -$815K -27,004 Closed
1 2
3
4 5

CPXX Hedge Fund Activity: Q3 2016 in Review

0 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) for Q3 2016, worth a combined $0 — down 100% from $944M a quarter earlier.

Sellers outnumbered buyers: 117 funds closed out of CPXX and 0 opened new positions — a net loss of 117 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Caxton Corporation, exiting entirely with an estimated $67.4M sold.

  • 0 institutional investors held CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) as of Q3 2016, down from 119 in Q2 2016.
  • Funds reported $0 of CELATOR PHARMACEUTICALS INC. COMMON STOCK stock for Q3 2016, down 100% quarter-over-quarter.
  • 0 funds opened new CELATOR PHARMACEUTICALS INC. COMMON STOCK positions in Q3 2016 and 117 closed out, a net change of -117 holders.
  • The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK seller in Q3 2016 was Caxton Corporation, an estimated $67.4M sold.

Based on aggregated 13F filings for Q3 2016.